Is the Recommendation of a Pelvic Lymphadenectomy in Conjunction with Radical Prostatectomy in Prostate Cancer Patients Justified? Report from a Multidisciplinary Expert Panel Meeting
Alexander Winter(Klinikum Oldenburg), L. Weißbach(Helios Universitätsklinikum Wuppertal), Christiane Roloff(LIV Pharma (Germany)), R. Harzmann, Johann Jakob Wendler(Otto-von-Guericke-Universität Magdeburg), Steffen Weikert(St. Hedwig-Krankenhaus)
Cited by 7
Related Papers
The Epidemiology of Renal Cell Carcinoma
|European Urology|2011|1k
IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial
|The Lancet Oncology|2016|218
The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
|European Journal of Cancer|2010|187
Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas
|International Journal of Molecular Medicine|2005|151
miRNA Profiling Identifies Candidate miRNAs for Bladder Cancer Diagnosis and Clinical Outcome
|Journal of Molecular Diagnostics|2013|144